Get started
Author

Erik van Beers

Observed names: E van Beers, E. van Beers, Erik Van Beers
OpenAlex ID: A5030004229
Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
2010 · Hugo M. Horlings, Carmen Lai, et al. · Clinical Cancer Research · 71
PDF
Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers
2010 · Henne Holstege, Erik van Beers, et al. · BMC Cancer · 43
PDF
Predicting response to alkylating chemotherapy in breast cancer patients using array comparative genomic hybridization.
2009 · MA Vollebergh, PM Nederlof, et al. · Cancer Research · 9
The Combination of SKY92 and ISS Provides a Powerful Tool to Identify Both High Risk and Low Risk Multiple Myeloma Cases, Validation in Two Independent Cohorts
2015 · Martin van Vliet, Joske Ubels, et al. · Blood · 6
Comparison Of Conventional, FISH and GEP Prognostic Factors In Multiple Myeloma: Introducing a Novel Risk Stratification
2013 · Rowan Kuiper, Martin van Vliet, et al. · Blood · 3
Supplementary Table S1 from Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
2023 · Hugo M. Horlings, Carmen Lai, et al.
Supplementary Table S4 from Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
2023 · Hugo M. Horlings, Carmen Lai, et al.
Supplementary Table S3 from Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
2023 · Hugo M. Horlings, Carmen Lai, et al.
Supplementary Table S2 from Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
2023 · Hugo M. Horlings, Carmen Lai, et al.
Data from Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
2023 · Hugo M. Horlings, Carmen Lai, et al.
Data from Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
2023 · Hugo M. Horlings, Carmen Lai, et al.
Supplementary Table S2 from Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
2023 · Hugo M. Horlings, Carmen Lai, et al.
Supplementary Table S3 from Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
2023 · Hugo M. Horlings, Carmen Lai, et al.
Supplementary Table S4 from Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
2023 · Hugo M. Horlings, Carmen Lai, et al.
Supplementary Table S1 from Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
2023 · Hugo M. Horlings, Carmen Lai, et al.
Ps1516 Cost‐effectiveness of Risk‐stratified Treatment in Transplant‐eligible Patients With Multiple Myeloma
2019 · A. Van Dongen ‐ Leunis, A. Sajjad, et al. · HemaSphere
Low-Risk Multiple Myeloma By SKY92+ISS Validated in the Multiple Myeloma Genomics Initiative Study
2015 · Erik van Beers, Martin van Vliet, et al. · Blood
Validation of the EMC92/SKY92 Signature in HOVON-87/Nmsg-18: Gene Expression Based Prognostication Is Applicable in Elderly Patients with Newly Diagnosed Multiple Myeloma
2015 · Mark van Duin, Rowan Kuiper, et al. · Blood
Array Cgh Aberrations in Non-brca1/2 Familial Breast Cancer
2010 · M. Didraga, Erik van Beers, et al. · Data Archiving and Networked Services (DANS)
Abstract 4820: A clinical test for BRCAness: Using array comparative genomic hybridization to predict benefit of high-dose, platinum-containing chemotherapy in ER-low/HER2-negative breast cancer patients
2010 · Marieke A. Vollebergh, Petra M. Nederlof, et al. · Cancer Research
Scientists & Societies
2005 · Erik van Beers, Anke Klerkx, et al. · Nature
Discovering genetic profiles by array-CGH in familial breast tumors
2005 · PM Nederlof, E van Beers, et al. · Breast Cancer Research
PDF
Works count: 23
Citation count: 132
H-index: 4
I10-index: 2
Year
Topic
Type